RESUMEN
Four transcriptional enhancers lie downstream of the immunoglobulin heavy chain locus: Calpha3'/hs3a, hs1,2, hs3b, and hs4. Although individually weak, these elements have strong transcriptional synergies when combined and they altogether behave as a locus control region. Previous knockout experiments in the 3' region have shown that both hs3a and hs1,2 are dispensable for normal expression and rearrangement of the IgH locus but that their replacement with a transcribed neo gene severely affects class switch recombination. Here we show that even in the absence of a neo gene, joint deletion of the last two 3' enhancers, hs3b and hs4, severely impairs germline transcription and class switching to most isotypes and may in addition affect mu gene expression in resting B cells.
Asunto(s)
Cambio de Clase de Inmunoglobulina/genética , Cadenas Pesadas de Inmunoglobulina/genética , Región de Control de Posición/genética , Recombinación Genética , Animales , Linfocitos B , Elementos de Facilitación Genéticos , Heterocigoto , Homocigoto , Isotipos de Inmunoglobulinas/biosíntesis , Inmunoglobulina M/biosíntesis , Cadenas mu de Inmunoglobulina/genética , Tejido Linfoide , Ratones , Ratones Transgénicos , ARN Mensajero/biosíntesis , Eliminación de Secuencia , Bazo/inmunologíaRESUMEN
Multiple DNA polymerases exist in eukaryotes. Polymerases alpha, delta and epsilon are mainly responsible for chromosomal DNA replication in the nucleus and are required for proliferation. In contrast, the repair polymerases beta and eta are not essential for cellular proliferation in yeast or mice, but a lack of either polymerase can lead, respectively, to defects in base excision repair or the ability to replicate past lesions induced by ultraviolet (UV) radiation [1-3]. Here, we have focused on polymerase zeta. This was first described as a non-essential product of the yeast REV3/REV7 genes involved in UV-induced mutagenesis, and was later implicated in trans-lesion synthesis [4,5]. Unlike in yeast, the mouse homologue (mRev3) was found to be essential for life. Homozygous mutant mice died in utero. Mutant embryos were considerably reduced in size at day 10.5 of development and usually aborted around day 12.5. It is likely that this block reflects a need for mRev3 in proliferative clonal expansion (rather than in the production of a particular cell type) as mutant blastocysts showed greatly diminished expansion of the inner cell mass in culture. Thus, mRev3 could be required to repair a form of externally induced DNA damage that otherwise accumulates during clonal expansion or, consistent with the high homology shared between its Rev7 partner and the mitotic checkpoint gene product Mad2 [6], mRev3 might play a role in cell proliferation and genomic stability even in the absence of environmentally induced damage.
Asunto(s)
ADN Polimerasa Dirigida por ADN/genética , Desarrollo Embrionario y Fetal/genética , Proteínas Fúngicas/genética , Genes Letales , Proteínas de Saccharomyces cerevisiae , Animales , Secuencia de Bases , Cartilla de ADN , Ratones , Ratones MutantesAsunto(s)
Regiones no Traducidas 3'/genética , Subgrupos de Linfocitos B/inmunología , Reordenamiento Génico de Cadena Pesada de Linfocito B , Genes de Inmunoglobulinas , Cadenas Pesadas de Inmunoglobulina/genética , Factores de Transcripción , Animales , Subgrupos de Linfocitos B/metabolismo , Sitios de Unión , Diferenciación Celular , Cromatina/ultraestructura , Replicación del ADN , Proteínas de Unión al ADN/fisiología , Elementos de Facilitación Genéticos , Regulación de la Expresión Génica , Humanos , Ratones , Ratones Transgénicos , Mutagénesis , Mutagénesis Insercional , Proteínas Nucleares/fisiología , Factor de Transcripción PAX5 , Ratas , Especificidad de la Especie , Transactivadores/fisiologíaRESUMEN
The B-cell antigen receptor (BCR) internalizes bound antigen such that antigen-derived peptides become associated with emigrating major histocompatibility complex (MHC) class II molecules for presentation to T cells. Experiments with B-cell transfectants reveal that BCR confers a specificity of intracellular targeting since chimeric antigen receptors which internalize antigen by virtue of a heterologous cytoplasmic domain do not necessarily give rise to presentation. In contrast, however, previous studies have shown that antigen binding to irrelevant cell surface molecules (e.g. transferrin receptor, MHC class I) can ultimately lead to presentation. The solution to this paradox appears to be that the intracellular targeting by BCR actually reflects an acceleration of antigen delivery. Depending on the nature of the BCR-antigen interaction, this accelerated targeting can be essential in determining whether or not internalization leads to significant presentation. Physiologically, the accelerated delivery of antigen by BCR could prove of particular importance early in the immune response when antigen-BCR interaction is likely to be poor.
Asunto(s)
Presentación de Antígeno , Antígenos/inmunología , Receptores de Antígenos de Linfocitos B/inmunología , Animales , Antígenos/genética , Antígenos H-2/genética , Antígenos H-2/inmunología , Antígenos de Histocompatibilidad Clase II/inmunología , Inmunoglobulina M/genética , Inmunoglobulina M/inmunología , Lipoproteínas LDL/genética , Lipoproteínas LDL/inmunología , Ratones , Muramidasa/genética , Muramidasa/inmunología , Nitrohidroxiyodofenilacetato/genética , Nitrohidroxiyodofenilacetato/inmunología , Ovalbúmina/genética , Ovalbúmina/inmunología , Receptores de Antígenos de Linfocitos B/genética , Células Tumorales CultivadasRESUMEN
Light chain deposition disease (LCDD) results from a propensity of some human monoclonal L chains to form tissue deposits. We designed an experimental model for in vivo expression of human kappa L chain sequences in mice and compared a somatically mutated LCDD chain with a closely related control kappa chain, both encoded by the unique V kappa IV gene. Mice secreting the LCDD chain but not those producing the control chain showed deposits with a distribution similar to that observed in patients. These data show that discrete changes in V region sequences can play a major role in tissue deposition of human L chains.
Asunto(s)
Modelos Animales de Enfermedad , Genes de Inmunoglobulinas , Región Variable de Inmunoglobulina/genética , Cadenas kappa de Inmunoglobulina/genética , Enfermedades Renales/etiología , Mieloma Múltiple/genética , Proteínas de Mieloma/genética , Secuencia de Aminoácidos , Animales , Anticuerpos Monoclonales/genética , Humanos , Hibridomas/metabolismo , Hibridomas/trasplante , Enfermedades Renales/genética , Enfermedades Renales/patología , Ratones , Ratones Endogámicos BALB C , Datos de Secuencia Molecular , Mieloma Múltiple/patología , Paraproteinemias/genética , Paraproteinemias/patología , Proteínas Recombinantes de Fusión/biosíntesis , Proteínas Recombinantes de Fusión/toxicidad , Neoplasias Retroperitoneales/genética , Neoplasias Retroperitoneales/patología , Alineación de Secuencia , Homología de Secuencia de Aminoácido , TransfecciónRESUMEN
Certain monoclonal Ig light chains (LC) are responsible for marked disturbances of proximal tubule cell functions (Fanconi's syndrome, FS). In patients with FS, intracellular crystal-like inclusions containing LC determinants are commonly found in plasma cells, macrophages, and renal tubular cells. In an attempt at understanding the pathogenesis of myeloma-associated FS, we recently determined the first complete primary sequence of a kappa-LC (CHEB) responsible for the disease. We now report on the primary structure of three other kappa-LC of the V kappa l variability subgroup associated with FS (TRE, TRO, and DEL). After PCR amplification, cDNA encoding these LC were sequenced. CHEB, TRE, and TRO LC genes were found to be highly homologous to the same germline gene O2/O12. These patients had numerous intracellular crystals, whereas the fourth patient, DEL, had no detectable crystals. The LC from the latter patient was homologous to another germline gene, O8/O18. Comparison of these LC sequences to previously reported LC of the V kappa l subgroup allowed identification of a number of unusual amino acid substitutions in the V region that had rarely or never been previously described at the corresponding positions. Some of these unusual substitutions affect highly conserved amino acids located either in an external loop (residue 30) or in inner (residues 48 and 55) and outer (positions 63 and 72) beta-sheets that may be important for the structure and binding properties of the kappa-chains. These and several other substitutions, some of them shared with amyloidogenic kappa-LC, could induce conformational alterations and represent a determinant pathogenic factor.
Asunto(s)
Síndrome de Fanconi/inmunología , Cadenas Ligeras de Inmunoglobulina/inmunología , Región Variable de Inmunoglobulina/inmunología , Secuencia de Aminoácidos , Secuencia de Bases , ADN Complementario/genética , ADN Complementario/aislamiento & purificación , Síndrome de Fanconi/patología , Humanos , Cadenas Ligeras de Inmunoglobulina/química , Cadenas Ligeras de Inmunoglobulina/genética , Región Variable de Inmunoglobulina/química , Región Variable de Inmunoglobulina/genética , Riñón/inmunología , Riñón/patología , Riñón/ultraestructura , Microscopía Electrónica , Datos de Secuencia Molecular , Alineación de SecuenciaRESUMEN
The sequences of two immunoglobulin gamma 1 heavy chains involved in the formation of non-amyloid tissue deposits were determined in two patients (RIC and THR) affected with plasma cell monoclonal proliferation and heavy-chain-deposition disease. The proliferating plasma cells of patients RIC and THR synthesized truncated gamma 1 chains of 45 kDa and 24 kDa, respectively, carrying internal deletions of the first constant (CH1) domain (RIC) or of the CH1, hinge and CH2 domains(THR). The shortened gamma chains were associated with lambda light chains in the monoclonal IgG component present in the serum from both patients but not in tissue deposits which lacked any detectable light chains. Bone marrow plasma cells from RIC contained short gamma 1 heavy-chain transcripts in which a VDJ exon related to the VH2 subgroup was directly joined to the hinge exon; plasma cells from THR contained short gamma 1 transcripts with a VDJ exon related to the VH3 subgroup joined to the CH3 exon. In both cases, the truncated transcripts carried precise deletions of complete exons and used regular splice sites at the variable/constant junction, consistent with the hypothesis that they originated from abnormal splicing of primary transcripts from the productively rearranged heavy-chain genes. Striking abnormalities of the variable regions were found, especially in framework regions, including replacement of an invariant tryptophan residue in protein from THR, hydrophobic residues most likely exposed to the solvent and inversion of charged amino acids probably exposed on the surface of the molecule.
Asunto(s)
Genes de Inmunoglobulinas/genética , Enfermedad de las Cadenas Pesadas/inmunología , Fragmentos de Inmunoglobulinas/química , Células Plasmáticas/inmunología , Secuencia de Aminoácidos , Secuencia de Bases , Médula Ósea/inmunología , ADN Complementario , Eliminación de Gen , Humanos , Fragmentos de Inmunoglobulinas/genética , Datos de Secuencia Molecular , Reacción en Cadena de la Polimerasa , Alineación de SecuenciaRESUMEN
Several cDNA expression vectors were constructed and tested by stable transfection into a murine lymphoid cell line in order to compare secretion rates of a human immunoglobulin (Ig) light chain (LC). When the cDNA was under transcriptional control of the SV40 promoter and enhancer and preceded by the SV40 19S late mRNA intron, a weak LC production was detected. Secretion rate was not improved by replacing the SV40 promoter and enhancer by a combination of a murine Ig heavy chain (HC) gene promoter and enhancer even with insertion of additional Ig enhancers. In contrast, replacement of the 19S intron by a large intron derived from a human Ig HC gene and containing the intronic enhancer dramatically increased the secretion rate. High-level production was also obtained with the same enhancer-containing intron placed downstream from the LC cDNA. Stable transfectants were obtained that secreted the human LC in amounts comparable to those obtained with Ig genes. Our results suggest that the SV40 19S late mRNA intron used in several expression vectors is not appropriate when the purpose is to produce large amounts of antibody molecules. By providing transcriptional, splicing and polyadenylation signals, the presently described vectors will be useful for easy cloning and high-level expression in lymphoid cells of cDNAs or PCR products encoding antibody molecules.
Asunto(s)
Expresión Génica , Genes de Inmunoglobulinas , Cadenas Ligeras de Inmunoglobulina/biosíntesis , Intrones , Animales , Reanimación Cardiopulmonar , Línea Celular , ADN Complementario , Elementos de Facilitación Genéticos , Vectores Genéticos , Humanos , Cadenas Pesadas de Inmunoglobulina/genética , Cadenas Ligeras de Inmunoglobulina/genética , Linfocitos , Ratones , Regiones Promotoras Genéticas , Mapeo Restrictivo , Virus 40 de los Simios/genética , Transcripción Genética , TransfecciónAsunto(s)
Inmunoglobulinas/química , Enfermedades Renales/inmunología , Paraproteinemias/inmunología , Amiloidosis/inmunología , Amiloidosis/patología , Enfermedad de las Cadenas Pesadas/inmunología , Enfermedad de las Cadenas Pesadas/patología , Humanos , Cadenas Ligeras de Inmunoglobulina/química , Enfermedades Renales/patología , Estructura Molecular , Paraproteinemias/patologíaRESUMEN
Monoclonal immunoglobulin deposition disease, a complication of overtly malignant or apparently benign immunoproliferative disorders, is a severe disease featuring tissue deposition of monoclonal light, light and heavy, or heavy chains. A number of converging arguments strongly suggest a direct pathogenetic role of structural abnormalities or peculiarities of variables regions of light and/or heavy chains (associated with deletions in the constant region for the heavy chains). Recent structural data on these abnormal immunoglobulin chains are reviewed.
Asunto(s)
Hipergammaglobulinemia/inmunología , Cadenas Pesadas de Inmunoglobulina/química , Cadenas Ligeras de Inmunoglobulina/química , Amiloidosis/inmunología , Enfermedad de las Cadenas Pesadas/inmunología , HumanosAsunto(s)
Enfermedad de las Cadenas Pesadas , Enfermedades Renales , Secuencia de Bases , Cartilla de ADN , Femenino , Enfermedad de las Cadenas Pesadas/genética , Enfermedad de las Cadenas Pesadas/inmunología , Enfermedad de las Cadenas Pesadas/patología , Humanos , Inmunoglobulina G/genética , Región Variable de Inmunoglobulina , Cadenas alfa de Inmunoglobulina , Enfermedades Renales/genética , Enfermedades Renales/inmunología , Enfermedades Renales/patología , Persona de Mediana Edad , Datos de Secuencia Molecular , Reacción en Cadena de la Polimerasa , ARN Mensajero/análisisRESUMEN
Monoclonal free L chains secreted in immunoproliferative disorders are frequently involved in renal complications, including a specific proximal tubule impairment, the Fanconi's syndrome, which is generally featured by intracellular crystallization of L chain-related material. In a patient with myeloma-associated Fanconi's syndrome, hexagonal crystals (most surrounded by smooth membranes) were found in kidney proximal tubular cells and bone marrow plasma cells and phagocytes. The sequence of the patient's monoclonal kappa-chain was deduced from that of identical kappa-cDNA clones from the tumoral plasma cells. Small protein-enriched gel filtration fractions from urine yielded crystals morphologically similar and with the same 60 A periodicity on electron micrographs as those found in the cells. N-terminal sequencing and mass spectrometry studies showed that the crystals contained a 107-amino acid fragment (with a C-terminal lysine) corresponding to the V domain together with a low proportion of the entire kappa-chain. In vitro trypsin and pepsin treatment of the native entire kappa-chain yielded a homogeneous V domain fragment which, contrary to other monoclonal kappa-chains, was completely resistant to further proteolytic attack. The patient's kappa-chain also displayed an unusual self-reactivity, as demonstrated by a Western blot technique. The peculiar proneness of the V domain to resist proteolysis and to form crystals might prevent the normal cell catabolism of the L chain and lead to crystallization and renal impairment.
Asunto(s)
Síndrome de Fanconi/inmunología , Región Variable de Inmunoglobulina/química , Cadenas kappa de Inmunoglobulina/química , Mieloma Múltiple/inmunología , Adulto , Secuencia de Aminoácidos , Secuencia de Bases , Cristalización , Síndrome de Fanconi/etiología , Humanos , Masculino , Datos de Secuencia Molecular , Mieloma Múltiple/complicacionesRESUMEN
Although structural abnormalities of monoclonal immunoglobulin light chains (LC) are suspected to play a determinant role in non-amyloid light chain deposition disease (LCDD), this condition is as yet poorly documented at the molecular level, since only three sequences have been reported to date. In a case of myeloma-associated LCDD, the patient's urine contained an unglycosylated kappa Bence Jones protein made up of dimers and monomers with an apparent molecular mass of 25,000 which was assigned to the V kappa I subgroup by N-terminal amino acid sequencing. The complete variable region sequence of the monoclonal kappa chain produced by the malignant plasma cells was amplified by polymerase chain reaction (PCR) using small amounts of material obtained by bone marrow aspiration. The sequence of three independently amplified cDNA clones derived from a normal-sized kappa messenger RNA was identical to that of the urinary kappa chain. The kappa mRNA had an overall normal structure made up of a V kappa I sequence rearranged to J kappa I. Several unusual features of the variable region (the first complete V kappa I sequence reported in LCDD) included three substitutions that introduced hydrophobic residues at spatially close positions. The strategy associating N-terminal sequence determination and cDNA cloning by PCR could help in accumulating new sequence data and improving our understanding of LCDD pathogenesis.
Asunto(s)
Inmunoglobulina G/genética , Cadenas kappa de Inmunoglobulina/genética , Paraproteinemias/genética , Secuencia de Aminoácidos , Secuencia de Bases , Proteína de Bence Jones/genética , Médula Ósea , Electroforesis en Gel de Poliacrilamida , Humanos , Datos de Secuencia Molecular , Mieloma Múltiple/genética , Reacción en Cadena de la Polimerasa , ARN/genéticaRESUMEN
The primary structure of three amyloid precursor light chains was deduced from the sequence of complementary DNA (cDNA) from bone marrow cells from patients affected with classical lambda (patient Air) or kappa (patient Arn) amyloidosis and from a patient (Aub) in whom lambda amyloid deposits were unusual by their perimembranous location in the kidney glomerulus. All three RNAs were of normal size, as estimated by Northern blotting, and encoded normal-sized light chains. The deduced light-chain sequence from patient Arn was related to the V kappa 1 subgroup, and included ten residues that had not been previously reported at these positions, only one of which (Leu-21) was located in a beta-sheet (4-2). The unusual presence of Asn-70 determined a potential N-glycosylation site. The sequence of the light chain from patient Air belonged to the V lambda 1 subgroup, and included three unusually located amino acid residues, one of which had already been reported in an amyloidogenic lambda-chain. The sequence of the light chain from patient Aub was related to the V lambda 3 subgroup, and contained five amino acid residues that had not previously been described at the corresponding positions; two of them (His-36 and Ser-77) were located in beta-sheets (3-1 and 4-3 respectively). This sequence was also peculiar because of the presence of numerous acidic residues in the complementarity-determining regions. Such unusual primary structures might be responsible for the amyloidogenic properties of these light-chain precursors.
Asunto(s)
Amiloidosis/genética , Cadenas Ligeras de Inmunoglobulina/genética , Precursores de Proteínas/genética , Secuencia de Aminoácidos , Amiloidosis/metabolismo , Secuencia de Bases , Northern Blotting , Médula Ósea/metabolismo , Células de la Médula Ósea , Células Cultivadas , Clonación Molecular , ADN , Glicosilación , Humanos , Cadenas Ligeras de Inmunoglobulina/metabolismo , Riñón/metabolismo , Riñón/patología , Datos de Secuencia Molecular , Precursores de Proteínas/metabolismo , ARN/metabolismoAsunto(s)
Inmunoglobulinas/química , Trastornos Inmunoproliferativos/inmunología , Amiloidosis/inmunología , Deleción Cromosómica , Genes de Inmunoglobulinas , Enfermedad de las Cadenas Pesadas/inmunología , Humanos , Cadenas Pesadas de Inmunoglobulina/genética , Cadenas Ligeras de Inmunoglobulina/genéticaRESUMEN
Previous data suggest that structural abnormalities of immunoglobulin light chains may be responsible for non-amyloid light chain deposition disease (LCDD). We report on the complete primary sequence deduced from complementary (c)DNA analysis of a normal-sized kappa chain in a case of myeloma-associated LCDD. The patient's urine contained a kappa type Bence-Jones protein made of monomers and dimers of an unglycosylated kappa chain. The bone marrow myeloma cells contained intracellular kappa and gamma chains by immunofluorescence. Biosynthesis experiments showed the production of normal-sized gamma chains and of kappa chains with the same apparent molecular mass (Mr) in SDS gels as the urinary kappa chain (26,000-27,000). These kappa chains were secreted as assembled IgG molecules and as a large excess of free monomers and dimers. The complete sequence of two identical cDNA clones derived from a normal-sized kappa messenger RNA indicated that this kappa chain belonged to the rare V kappa IV subgroup. The kappa mRNA had an overall normal structure made up of the V kappa IV sequence rearranged to J kappa 1 and followed by a normal constant exon of the Km(3) allotype. The variable region differed from the V kappa IV-J kappa 1 germline sequence by 17 amino acid substitutions. The peculiar sequence of the variable region of this kappa chain of a rare subgroup might relate to its tissue deposition.